Evidence map›Paper›PMID 35073786›Full record

ArticleCell transplantation

Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases.

Jiahua Ding, Yongjun Fang, Rongfu Zhou, Yan Gu, Shengnan Du, Qin Lu, Qingqing Yue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jiahua DingZhongDa Hospital of Southeast University, Nanjing, China.ORCID 0000-0002-0832-0207
Yongjun FangChildren's Hospital of Nanjing Medical University, Nanjing, China.
Rongfu ZhouNanjing Drum Tower Hospital and Hospital of Nanjing University Medical School, Nanjing, China.
Yan GuNanjing Second Hospital, Nanjing, China.ORCID 0000-0003-4535-8199
Shengnan DuZhongDa Hospital of Southeast University, Nanjing, China.
Qin LuChildren's Hospital of Nanjing Medical University, Nanjing, China.
Qingqing YueSoutheast University Medical College, Nanjing, China.
Second Affiliated Hospital of Nanjing Medical University · CNZhongda Hospital Southeast University · CNNanjing Drum Tower Hospital · CNNanjing Second Hospital · CNSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore a more effective conditioning regimen for umbilical cord blood transplantation (UCBT) to treat hematologic malignancies, we conducted a cohort study of a fludarabine/busulfan/cytarabine plus cyclophosphamide 200 mg/kg regimen. Forty-two consecutive patients with leukemia, myelodysplastic syndrome, or lymphoma received the regimen. The median number of infused total nucleated cells per kilogram was 5.5 × 10

Indexed as

Cord Blood Stem Cell TransplantationGraft vs Host DiseaseHematologic DiseasesHematologic NeoplasmsCohort StudiesHumansRetrospective StudiesTransplantation Conditioningcord bloodgraft survivalhematopoietic stem cellsmalignant hematologic diseasesT cells

Identifiers

PMID35073786
PMCPMC8793423
OpenAlexW4207051654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.